recognizing the role of capmatinib for metex14 in nsclc
Published 3 months ago • 22 plays • Length 13:00Download video MP4
Download video MP3
Similar videos
-
0:49
the importance of metex14 testing in nsclc
-
1:25
dr. wolf on updated findings with capmatinib in metex14-mutant nsclc
-
2:49
the challenges of treating metex14 nsclc
-
1:32
assessing capmatinib for lung cancer
-
13:06
met exon 14 mutations in mnsclc
-
1:02
investigating met exon 14 mutations in patients with nsclc
-
1:49
what is capmatinib? efficacy and safety of a targeted cancer drug used in a met gene alteration
-
1:11
detecting the met exon 14 skipping mutations in nsclc
-
3:24
impact of met inhibitors in met exon 14-mutant nsclc
-
2:51
impaired c-met receptor degradation mediated by met exon 14 mutations in non–small-cell lung cancer
-
3:40
metex14 sas (met exon 14 skipping alterations) in non-small cell lung cancer
-
1:18
amivantamab for nsclc with met exon 14 skipping mutations
-
6:21
intertumoral molecular heterogeneity of non-small cell lung cancer with met exon 14 skipping – d...
-
0:58
vision trial produces positive data in nsclc with met exon 14 mutations
-
1:22
gregory j. riely on the identification and treatment of patients with met exon 14 skipping mutations
-
5:04
c-met role as biomarker and player in innate and acquired resistance in non-small-cell lung cancer
-
0:54
what is a met mutation in non-small cell lung cancer (nsclc)?
-
5:55
patient selection in braf-mutant nsclc
-
56:48
detection of therapeutically targetable mutations in nsclc: